Document Detail

Synthesis of 2-(allylthio)pyrazines as a novel cancer chemopreventive agent.
MedLine Citation:
PMID:  11235806     Owner:  NLM     Status:  MEDLINE    
2-(Allylthio)pyrazine derivatives were designed as a novel cancer chemopreventive agent that functions through selective inhibtion of cytochrome P-450 and induction of phase II enzymes involved in the detoxification of carcinogens. A practical preparation method of 2-(allylthio) pyrazine derivatives was established by the reaction of 2-mercaptopyrazine and allylbromides in the presence of a catalytic antioxidant, DABCO (1,4-diazabicyclo[2,2,2] octane), in dimethylformamide at below 50 degrees C.
J W Lee; B Lee; N D Kim
Related Documents :
3529226 - Recent advances in contrast agents.
9046056 - Biomarkers of squamous cell carcinoma of the head and neck.
11235806 - Synthesis of 2-(allylthio)pyrazines as a novel cancer chemopreventive agent.
21820706 - Prostate cancer risk alleles and their associations with other malignancies.
12590026 - Validation study of the japanese version of the brief fatigue inventory.
17318376 - Dnmt3b 39179gt polymorphism and the risk of adenocarcinoma of the colon in koreans.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Archives of pharmacal research     Volume:  24     ISSN:  0253-6269     ISO Abbreviation:  Arch. Pharm. Res.     Publication Date:  2001 Feb 
Date Detail:
Created Date:  2001-03-08     Completed Date:  2001-06-07     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8000036     Medline TA:  Arch Pharm Res     Country:  Korea (South)    
Other Details:
Languages:  eng     Pagination:  16-20     Citation Subset:  IM    
Yuan Research Center, Kyonggi-Do, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticarcinogenic Agents / chemical synthesis*,  therapeutic use
Enzyme Inhibitors / chemical synthesis*,  therapeutic use
Neoplasms / drug therapy,  prevention & control
Pyrazines / chemical synthesis*,  therapeutic use
Reg. No./Substance:
0/2-(allylthio)pyrazine; 0/Anticarcinogenic Agents; 0/Enzyme Inhibitors; 0/Pyrazines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Gene medicine : a new field of molecular medicine.
Next Document:  Synthesis and antihypertensive activity of certain Mannich Bases of 2-ethoxycarbonylindoles and 5H-p...